{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:22:48Z","timestamp":1787325768774,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lenus Pharma GesmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00404-019-05194-w","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T13:48:13Z","timestamp":1558100893000},"page":"455-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial"],"prefix":"10.1007","volume":"300","author":[{"given":"Marlene","family":"Hager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Egarter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-5262","authenticated-orcid":false,"given":"Johannes","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"issue":"6","key":"5194_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745\u20132749","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5194_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC (2016) Clinical practice. Polycystic ovary syndrome. N Engl J Med 375(1):54\u201364","journal-title":"N Engl J Med"},{"issue":"5","key":"5194_CR3","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1210\/jc.2002-021528","volume":"88","author":"E Diamanti-Kandarakis","year":"2003","unstructured":"Diamanti-Kandarakis E, Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Nestler JE (2003) A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. J Clin Endocrinol Metab 88(5):1927\u20131932","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5194_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa063971","volume":"356","author":"RS Legro","year":"2007","unstructured":"Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER, Network Cooperative Multicenter Reproductive Medicine (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356(6):551\u2013566","journal-title":"N Engl J Med"},{"key":"5194_CR5","doi-asserted-by":"crossref","unstructured":"Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2012) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, d-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev CD003053","DOI":"10.1002\/14651858.CD003053.pub5"},{"issue":"1","key":"5194_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6874-1-3","volume":"1","author":"ES Sills","year":"2001","unstructured":"Sills ES, Perloe M, Tucker MJ, Kaplan CR, Genton MG, Schattman GL (2001) Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports. BMC Womens Health 1(1):3","journal-title":"BMC Womens Health"},{"issue":"1","key":"5194_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12906-017-2011-x","volume":"17","author":"S Arentz","year":"2017","unstructured":"Arentz S, Smith CA, Abbott J, Bensoussan A (2017) Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis. BMC Complement Altern Med 17(1):500","journal-title":"BMC Complement Altern Med"},{"issue":"3","key":"5194_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-Ram\u00edrez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 19(3):268\u2013288","journal-title":"Hum Reprod Update"},{"issue":"1","key":"5194_CR9","first-page":"1","volume":"13","author":"L Amini","year":"2015","unstructured":"Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Ziaee S (2015) Antioxidants and management of polycystic ovary syndrome in Iran: a systematic review of clinical trials. Iran J Reprod Med 13(1):1\u20138","journal-title":"Iran J Reprod Med"},{"issue":"4","key":"5194_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.endinu.2017.12.010","volume":"65","author":"J Mejia-Montilla","year":"2018","unstructured":"Mejia-Montilla J, Reyna-Villasmil E, Dom\u00ednguez-Brito L, Naranjo-Rodr\u00edguez C, Noriega-Verdugo D, Padilla-Samaniego M, Vargas-Olalla V (2018) Supplementation with omega-3 fatty acids and plasma adiponectin in women with polycystic ovary syndrome. Endocrinol Diabetes Nutr 65(4):192\u2013199","journal-title":"Endocrinol Diabetes Nutr"},{"key":"5194_CR11","doi-asserted-by":"crossref","unstructured":"Jamilian M, Shojaei A, Samimi M, Afshar Ebrahimi F, Aghadavod E, Karamali M, Taghizadeh M, Jamilian H, Alaeinasab S, Jafarnejad S, Asemi Z (218) The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome. J Affect Disord 229:41\u201347.","DOI":"10.1016\/j.jad.2017.12.049"},{"issue":"4","key":"5194_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1055\/s-0043-119751","volume":"126","author":"G Mirmasoumi","year":"2018","unstructured":"Mirmasoumi G, Fazilati M, Foroozanfard F, Vahedpoor Z, Mahmoodi S, Taghizadeh M, Esfeh NK, Mohseni M, Karbassizadeh H, Asemi Z (2018) The effects of flaxseed oil omega-3 fatty acids supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind placebo-controlled trial. Exp Clin Endocrinol Diabetes 126(4):222\u2013228","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"5194_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-0042-117773","volume":"125","author":"FA Ebrahimi","year":"2017","unstructured":"Ebrahimi FA, Samimi M, Foroozanfard F, Jamilian M, Akbari H, Rahmani E, Ahmadi S, Taghizadeh M, Memarzadeh MR, Asemi Z (2017) The effects of omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: a randomized, double-blind placebo-controlled trial. Exp Clin Endocrinol Diabetes 125(6):353\u2013359","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"5194_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.mce.2016.09.008","volume":"439","author":"E Rahmani","year":"2017","unstructured":"Rahmani E, Samimi M, Ebrahimi FA, Foroozanfard F, Ahmadi S, Rahimi M, Jamilian M, Aghadavod E, Bahmani F, Taghizadeh M, Memarzadeh MR, Asemi Z (2017) The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol Cell Endocrinol 439:247\u2013255","journal-title":"Mol Cell Endocrinol"},{"key":"5194_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jtemb.2016.01.002","volume":"34","author":"F Mohammad Hosseinzadeh","year":"2016","unstructured":"Mohammad Hosseinzadeh F, Hosseinzadeh-Attar MJ, Yekaninejad MS, Rashidi B (2016) Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: a randomized, double blinded, placebo controlled clinical trial. J Trace Elem Med Biol 34:56\u201361","journal-title":"J Trace Elem Med Biol"},{"issue":"3","key":"5194_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0035-1559604","volume":"48","author":"M Razavi","year":"2016","unstructured":"Razavi M, Jamilian M, Kashan ZF, Heidar Z, Mohseni M, Ghandi Y, Bagherian T, Asemi Z (2016) Selenium supplementation and the effects on reproductive outcomes, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome. Horm Metab Res 48(3):185\u2013190","journal-title":"Horm Metab Res"},{"key":"5194_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1345\/aph.1Q514","volume":"46","author":"SM Sirmans","year":"2012","unstructured":"Sirmans SM, Weidman-Evans E, Everton V, Thompson D (2012) Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications. Ann Pharmacother 46:403\u2013418","journal-title":"Ann Pharmacother"},{"issue":"2","key":"5194_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.dsx.2016.06.025","volume":"11","author":"A Sadeghi","year":"2017","unstructured":"Sadeghi A, Djafarian K, Mohammadi H, Shab-Bidar S (2017) Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: meta-analysis of randomized controlled trials. Diabetes Metab Syndr 11(2):157\u2013162","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"5194_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1055\/s-0042-105288","volume":"48","author":"M Hajishafiee","year":"2016","unstructured":"Hajishafiee M, Askari G, Iranj B, Ghiasvand R, Bellissimo N, Totosy de Zepetnek J, Salehi-Abargouei A (2016) The effect of n-3 polyunsaturated fatty acid supplementation on androgen status in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials. Horm Metab Res 48(5):281\u2013289","journal-title":"Horm Metab Res"},{"issue":"3","key":"5194_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09513590.2017.1381680","volume":"34","author":"E Rahmani","year":"2018","unstructured":"Rahmani E, Jamilian M, Samimi M, Zarezade Mehrizi M, Aghadavod E, Akbari E, Tamtaji OR, Asemi Z (2018) The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome. Gynecol Endocrinol 34(3):217\u2013222","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"5194_CR21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/cen.13288","volume":"86","author":"M Samimi","year":"2017","unstructured":"Samimi M, Zarezade Mehrizi M, Foroozanfard F, Akbari H, Jamilian M, Ahmadi S, Asemi Z (2017) The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 86(4):560\u2013566","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5194_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","volume":"89","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","unstructured":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89:505\u2013522","journal-title":"Fertil Steril"},{"issue":"3","key":"5194_CR23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/humrep\/dem426","volume":"23","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","unstructured":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23(3):462\u2013477","journal-title":"Hum Reprod"},{"key":"5194_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2337\/diacare.22.1.141","volume":"22","author":"DA Ehrmann","year":"1999","unstructured":"Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141\u2013146","journal-title":"Diabetes Care"},{"issue":"30","key":"5194_CR25","doi-asserted-by":"publisher","first-page":"28220","DOI":"10.1074\/jbc.M302297200","volume":"278","author":"L Papucci","year":"2003","unstructured":"Papucci L, Schiavone N, Witort E, Donnini M, Lapucci A, Tempestini A, Formigli L, Zecchi-Orlandini S, Orlandini G, Carella G, Brancato R, Capaccioli S (2003) Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J Biol Chem 278(30):28220\u201328228","journal-title":"J Biol Chem"},{"key":"5194_CR26","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1056\/NEJM199910073411515","volume":"341","author":"D Armanini","year":"1999","unstructured":"Armanini D, Bonanni G, Palermo M (1999) Reduction of serum testosterone in men by licorice. N Engl J Med 341:1158","journal-title":"N Engl J Med"},{"key":"5194_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/s-2003-42724","volume":"111","author":"D Armanini","year":"2003","unstructured":"Armanini D, Bonanni G, Mattarello MJ, Fiore C, Sartorato P, Palermo M (2003) Licorice consumption and serum testosterone in healthy man. Exp Clin Endocrinol Diabetes 111:341\u2013343","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"5194_CR28","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/0002-9378(88)90595-9","volume":"159","author":"RL Barbieri","year":"1988","unstructured":"Barbieri RL, Rein MS, Hornstein MD, Ryan KJ (1988) Rat Leydig cell and granulosa cells 17-keto reductase activity: subcellular localization and substrate specificity. Am J Obstet Gynecol 159:1564\u20131569","journal-title":"Am J Obstet Gynecol"},{"key":"5194_CR29","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1016\/S0021-9258(19)70665-6","volume":"255","author":"K Bogovich","year":"1980","unstructured":"Bogovich K, Payne AH (1980) Purification of rat testicular microsomal 17-ketosteroid reductase. Evidence that 17-ketosteroid reductase and 17 beta-hydroxysteroid dehydrogenase are distinct enzymes. J Biol Chem 255:5552\u20135559","journal-title":"J Biol Chem"},{"key":"5194_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0039-128X(90)90024-6","volume":"55","author":"SA Latif","year":"1990","unstructured":"Latif SA, Conca TJ, Morris DJ (1990) The effects of the licorice derivative, glycyrrhetinic acid, on hepatic 3 alpha- and 3 beta-hydroxysteroid dehydrogenases and 5 alpha- and 5 beta-reductase pathways of metabolism of aldosterone in male rats. Steroids 55:52\u201358","journal-title":"Steroids"},{"key":"5194_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1507\/endocrj1954.35.333","volume":"35","author":"K Sakamoto","year":"1988","unstructured":"Sakamoto K, Wakabayashi K (1988) Inhibitory effect of glycyrrhetinic acid on testosterone production in rat gonads. Endocrinol Jpn 35:333\u2013342","journal-title":"Endocrinol Jpn"},{"key":"5194_CR32","first-page":"789","volume":"40","author":"K Takahashi","year":"1988","unstructured":"Takahashi K, Yoshino K, Shirai T, Nishigaki A, Araki Y, Kitao M (1988) Effect of traditional herbal medicine (Shakuyaku-Kanzo-To) on testosterone secretion in patients with polycystic ovary syndrome detected by ultrasound. Acta Obstet Gynaecol Jpn 40:789\u2013792","journal-title":"Acta Obstet Gynaecol Jpn"},{"key":"5194_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1142\/S0192415X91000119","volume":"19","author":"T Takeuchi","year":"1991","unstructured":"Takeuchi T, Nishii O, Okamura T, Yaginuma T (1991) Effect of paeoniflorin, glycyrrhizin and glycyrrhetinic acid on ovarian androgen production. Am J Chin Med 19:73\u201378","journal-title":"Am J Chin Med"},{"issue":"2","key":"5194_CR34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jcb.22541","volume":"110","author":"PL Yu","year":"2010","unstructured":"Yu PL, Pu HF, Chen SY, Wang SW, Wang PS (2010) Effects of catechin, epicatechin and epigallocatechin gallate on testosterone production in rat leydig cells. J Cell Biochem 110(2):333\u2013342","journal-title":"J Cell Biochem"},{"key":"5194_CR35","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1093\/jn\/133.10.3275S","volume":"133","author":"B Frei","year":"2003","unstructured":"Frei B, Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275\u20133384","journal-title":"J Nutr"},{"key":"5194_CR36","first-page":"499","volume":"88","author":"N Farahi","year":"2013","unstructured":"Farahi N, Zolotor A (2013) Recommendations for preconception counseling and care. Am Fam Physician 88:499\u2013506","journal-title":"Am Fam Physician"},{"issue":"4","key":"5194_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/cen.12451","volume":"81","author":"F Bahmani","year":"2014","unstructured":"Bahmani F, Karamali M, Shakeri H, Asemi Z (2014) The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial. Clin Endocrinol (Oxf) 81(4):582\u2013587","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"5194_CR38","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/mnfr.201400033","volume":"58","author":"Z Asemi","year":"2014","unstructured":"Asemi Z, Karamali M, Esmaillzadeh A (2014) Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Mol Nutr Food Res 58(7):1465\u20131473","journal-title":"Mol Nutr Food Res"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-019-05194-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T05:19:27Z","timestamp":1721279967000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-019-05194-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["5194"],"URL":"https:\/\/doi.org\/10.1007\/s00404-019-05194-w","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"10 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M. Imhof and J. Ott received speaker honorarium for lecturing from Lenus Pharma GesmbH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. On July 15th, 2017, the study was approved by the Institutional Review Board of the Medical University of Vienna (IRB number: 1232\/2016). The study was registered on ClinicalTrials.gov (Clinical Trials ID: NCT03306745).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}